Scarab Genomics, LLC
6 products found

Scarab Genomics, LLC products

Clean Genome E. coli strains

Clean Genome - Robust Bacterial Fermentation

Clean Genome® is the most robust bacterial fermentation host for general/routine recombinant protein expression and nucleic acid production

Technology

Clean Genome E. coli - Technology

Clean Genome® E. coli has eliminated inherent troublesome and unnecessary genes to create a production host that generates recombinant proteins and nucleic acids efficiently and continuously without compromising the product or the process.  All strains are derived from the revolutionary MDS42 reduced genome strain described in Science 312:1044-6, and are further deleted to create the MDS69 series (see below).


C-Flow - Continuous Fermentation Technology

Our patented C-Flow™ continuous fermentation process is designed to produce large quantities of biopharmaceuticals with small scale inexpensive equipment, saving dramatically on costs. The C-Flow™ process was developed using Clean Genome® E. coli strains expressing recombinant CRM197, a carrier protein used to enhance the immunogenicity of poorly immunogenic carbohydrates in conjugated vaccines.

Vaccine Carrier Proteins

Protein Conjugate Vaccines

Protein D is a 42 kDa surface-exposed lipoprotein from Haemophilus influenzae that is utilized as an effective carrier protein for polysaccharides and haptens in human conjugated vaccines to enhance immunogenicity while maintaining disease antigen specificity. The effectiveness of this approach has been shown with GSK’s Synflorix®, GSK’s Pneumococcal Conjugate, which contains Protein D conjugated to weak antigenic sugars to render them more immunogenic while maintaining disease specificity.

Protein

Cross-Reactive Material 197 (CRM197) is a non-toxic mutant form of the 58-kd diphtheria toxin that serves as a carrier protein for polysaccharides and haptens in a number of conjugate vaccines, to enhance their immunogenicity. The effectiveness of this approach has been shown with Prevnar®, Pfizer’s Pneumococcal conjugate vaccine, which contains CRM197 conjugated to weakly antigenic sugars to render the vaccine more immunogenic while maintaining disease specificity.